NYSE:PRLB - Proto Labs Stock Price, Forecast & News

Proto Labs trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRLB."

Proto Labs Inc (NYSE:PRLB) posted its quarterly earnings results on Thursday, February, 6th. The industrial products company reported $0.63 EPS for the quarter, meeting the Zacks' consensus estimate of $0.63. The industrial products company had revenue of $111.90 million for the quarter, compared to analysts' expectations of $111.95 million. Proto Labs had a net margin of 13.88% and a return on equity of 11.31%. The business's revenue for the quarter was down .8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.74 earnings per share. View Proto Labs' Earnings History.

Proto Labs is scheduled to release their next quarterly earnings announcement on Thursday, April 23rd 2020. View Earnings Estimates for Proto Labs.

Proto Labs issued an update on its first quarter earnings guidance on Thursday, February, 6th. The company provided earnings per share (EPS) guidance of $0.50-0.58 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.67. The company issued revenue guidance of $111-117 million, compared to the consensus revenue estimate of $115.93 million.

5 brokers have issued twelve-month target prices for Proto Labs' shares. Their forecasts range from $84.00 to $84.00. On average, they expect Proto Labs' share price to reach $84.00 in the next twelve months. This suggests that the stock has a possible downside of 16.3%. View Analyst Price Targets for Proto Labs.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Proto Labs in the last year. There are currently 5 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Proto Labs.

News coverage about PRLB stock has been trending very negative recently, InfoTrie Sentiment reports. The research group scores the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Proto Labs earned a coverage optimism score of -3.4 on InfoTrie's scale. They also gave media coverage about the industrial products company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Proto Labs.

Some companies that are related to Proto Labs include Illinois Tool Works (ITW), Ingersoll-Rand (IR), Parker-Hannifin (PH), Stanley Black & Decker (SWK), Dover (DOV), Xylem (XYL), IDEX (IEX), Nordson (NDSN), Graco (GGG), Snap-on (SNA), Gardner Denver (GDI), Pentair (PNR), Woodward, Inc.Common Stock (WWD), Donaldson (DCI) and Middleby (MIDD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Proto Labs investors own include Brainstorm Cell Therapeutics (BCLI), Netflix (NFLX), Tesla (TSLA), NVIDIA (NVDA), Starbucks (SBUX), Intel (INTC), Walt Disney (DIS), Baidu (BIDU), Alphabet (GOOG) and Intuitive Surgical (ISRG).

Proto Labs' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (5.64%), ARK Investment Management LLC (3.01%), State Street Corp (2.88%), Sumitomo Mitsui Trust Holdings Inc. (2.42%), Nikko Asset Management Americas Inc. (2.42%) and ArrowMark Colorado Holdings LLC (2.21%). Company insiders that own Proto Labs stock include Arthur R Baker III, John B Goodman, John Way, Robert Bodor and Sven Wehrwein. View Institutional Ownership Trends for Proto Labs.

PRLB stock was sold by a variety of institutional investors in the last quarter, including Amundi Pioneer Asset Management Inc., Summit Creek Advisors LLC, Riverbridge Partners LLC, Blair William & Co. IL, Bank of America Corp DE, Covenant Asset Management LLC, Arizona State Retirement System and Russell Investments Group Ltd.. View Insider Buying and Selling for Proto Labs.

PRLB stock was bought by a variety of institutional investors in the last quarter, including ArrowMark Colorado Holdings LLC, Nikko Asset Management Americas Inc., Sumitomo Mitsui Trust Holdings Inc., ARK Investment Management LLC, Goldman Sachs Group Inc., Marshall Wace LLP, Great West Life Assurance Co. Can and Marshall Wace North America L.P.. View Insider Buying and Selling for Proto Labs.

Shares of PRLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of PRLB stock can currently be purchased for approximately $100.32.

Proto Labs has a market capitalization of $2.68 billion and generates $458.73 million in revenue each year. The industrial products company earns $63.65 million in net income (profit) each year or $2.35 on an earnings per share basis. Proto Labs employs 2,487 workers across the globe.View Additional Information About Proto Labs.

The official website for Proto Labs is http://www.protolabs.com/.

Proto Labs' mailing address is 5540 Pioneer Creek Drive, Maple Plain MN, 55359. The industrial products company can be reached via phone at 763-479-3680 or via email at [email protected]